Project information
The role of transposable element activity in hematological malignacies
- Project Identification
- GA19-11299S
- Project Period
- 3/2019 - 12/2021
- Investor / Pogramme / Project type
-
Czech Science Foundation
- Standard Projects
- MU Faculty or unit
-
Central European Institute of Technology
- Ilgar Mamedov, PhD
- Cooperating Organization
-
University Hospital Brno-Bohunice
- Responsible person Mgr. Karla Plevová, Ph.D.
Stručná anotace projektu.
Publications
Total number of publications: 12
2022
-
Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes
BMC Cancer, year: 2022, volume: 22, edition: 1, DOI
-
Retroelement activity in hematological malignances.
Year: 2022, type: Conference abstract
-
The Absence of Retroelement Activity Is Characteristic for Childhood Acute Leukemias and Adult Acute Lymphoblastic Leukemia
International Journal of Molecular Sciences, year: 2022, volume: 23, edition: 3, DOI
2021
-
Detekce transpozibilních elementů u hematologických malignit.
Year: 2021, type: Conference abstract
-
Exploring transposone activity in hematological malignances.
Year: 2021, type: Conference abstract
-
Klinický dopad a evoluce minoritních TP53-mutovaných klonů v kontextu různých terapeutických režimů u CLL.
Year: 2021, type: Conference abstract
-
Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options
Blood, year: 2021, volume: 138, edition: 25, DOI
2020
-
LYNX (Lymphoid NGS): a versatile NGS panel for comprehensive analysis of molecular markers with clinical relevance in lymphoproliferative disorders
Year: 2020, type: Conference abstract
-
Minor-clone TP53 mutations in CLL patients entering first-line treatment: clonal evolution and clinical impact.
Year: 2020, type: Conference abstract
-
The impact of transposable elements in hematological malignances.
Year: 2020, type: Conference abstract